Palisade Bio has reported positive outcomes from the Phase Ib open-label cohort of an ileocolonic-targeted PDE4 inhibitor, ...

Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda (TAK), ...

So let’s get into it. Here’s everything you need to know to address uncommon UC symptoms and seize back control of your ...

Microbiotica has completed patient recruitment for its phase 1b trial, COMPOSER-1, evaluating MB310 in adults with ulcerative ...

Juvenile idiopathic arthritis, older age, and concomitant immunomodulation delay the onset of psoriasiform dermatitis in ...

AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed ...

Dawson's Creek actor James van der Beek shares how subtle bowel changes were the first warning sign of his stage 3 colorectal ...

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live ...

“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...

The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new research suggests.